June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Identification and Characterization of Genetic Factors Responsible for Cavitary Optic Disc Anomalies
Author Affiliations & Notes
  • Ralph Hazlewood
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Ben Roos
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Robert Honkanen
    Ophthalmology, State University of New York at Stony Brook, Stony Brook, NY
  • Lee Jampol
    Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL
  • Wallace Alward
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Young Kwon
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
  • Edwin Stone
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Howard Hughes Medical Institute, Iowa City, IA
  • John Fingert
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA
    Anatomy and Cell Biology, University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships Ralph Hazlewood, None; Ben Roos, None; Robert Honkanen, None; Lee Jampol, Pfizer (C), Baxter International (C), Stem Cell Organization/Quintiles (C); Wallace Alward, None; Young Kwon, None; Edwin Stone, None; John Fingert, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6231. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ralph Hazlewood, Ben Roos, Robert Honkanen, Lee Jampol, Wallace Alward, Young Kwon, Edwin Stone, John Fingert; Identification and Characterization of Genetic Factors Responsible for Cavitary Optic Disc Anomalies. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6231.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To identify and characterize the gene that causes autosomal dominant, congenital malformations of the optic nerve known as cavitary optic disc anomaly (CODA) in a multiplex family with 17 affected members. Features of the nerve disease in CODA closely resemble that of glaucoma (excavated optic nerve head appearance) that occurs in the absence of elevated IOP, suggesting that the gene that causes CODA may also contribute to the pathophysiology of glaucoma.

Methods: The gene that causes CODA was previously mapped to a 13.5Mb locus on chromosome 12q14. The proband of the CODA pedigree was tested for copy number variations (CNVs) in the chromosome 12q14 region with custom comparative genomic hybridization using the NimbleGen platform (Madison, WI). CNVs were confirmed with quantitative PCR in the proband and in the remaining 16 affected family members as well as in a panel of 78 controls. Confirmed CNVs were analyzed for their effect on downstream genes using a luciferase reporter gene construct (pGL3, Promega, Madison, WI) in HEK293T cells.

Results: CGH experiments identified a triplication of a 6kb segment of DNA upstream of matrix metalloproteinase 19 (MMP19) in the proband of the CODA pedigree. Quantitative PCR experiments confirmed that the MMP19 promoter CNV is present in the proband as well as in the additional 16 affected family members. No control subjects carried this mutation. Furthermore there were no instances of this variant in the database of genomic variants (projects.tcag.ca/variation). The luciferase reporter gene assay showed that the 6kb sequenced spanned by the CNV in CODA patients increased luciferase activity and functioned as a transcription enhancer. Moreover, a similar analysis of overlapping subdivisions of the DNA sequence in the 6kb CNV showed that a 1kb segment had a strong positive influence (8-fold higher) on downstream gene expression.

Conclusions: We have identified a copy number variation mutation in the promoter sequence of the MMP19 gene that co-segregates with CODA in our large 17 member pedigree. Moreover we have shown that the CNV spans DNA sequences that powerfully enhance downstream genes (i.e. MMP19). These functional data strongly suggest that the genetic defects in MMP19 cause CODA and that over-activity of this gene has an important role in the pathogenesis of this optic nerve disease.

Keywords: 539 genetics • 627 optic disc • 629 optic nerve  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×